1. Immunology/Inflammation
  2. CD47
  3. KWAR 23

KWAR23 is an anti-human SIRPα antibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research.

For research use only. We do not sell to patients.

KWAR 23 Chemical Structure

KWAR 23 Chemical Structure

CAS No. : 2243227-60-1

Size Price Stock Quantity
1 mg USD 620 In-stock
5 mg USD 1380 In-stock
10 mg USD 2200 In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

KWAR23 is an anti-human SIRPα antibody. KWAR23 binds human SIRPα with high affinity and disrupts its binding to CD47. KWAR23 shows antitumor activity in combination with tumor-opsonizing antibodies and can be used in cancer immunotherapy research[1].

Species

Human

In Vitro

KWAR 23 (0-1 μM; 4 h) shows antitumor activity of human neutrophil and macrophage[1].
KWAR 23 induces human macrophage-dependent phagocytosis in human tumor-derived cell lines[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human macrophages and lymphoma cells
Concentration: 0-1 μM
Incubation Time: 4 h
Result: Showed human macrophages and neutrophils killing tumor cells following treatment with KWAR23.
In Vivo

KWAR23 (intraperitoneal injection; 10 mg/kg; every other day; 21 d) exhibits effective antitumor activity in a human SIRPA knockin mouse model[1].
KWAR23 enhances neutrophil and macrophage antitumor activity in SRG Mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SIRPA knock-in mouse model injected with Burkitt’s lymphoma cells[1]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection; 10 mg/kg; every other day; 21 d
Result: Led to strong inhibition of tumor growth when combined with Rituximab.
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[KWAR 23]

Shipping

Shipping with dry ice.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
KWAR 23
Cat. No.:
HY-P99175
Quantity:
MCE Japan Authorized Agent: